- Home
- NCTY vs XTNT Comparison
NCTY vs XTNT Comparison
Compare NCTY & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCTY
- XTNT
- Stock Information
- Founded
- NCTY 1999
- XTNT N/A
- Country
- NCTY China
- XTNT United States
- Employees
- NCTY N/A
- XTNT N/A
- Industry
- NCTY Business Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NCTY Consumer Discretionary
- XTNT Health Care
- Exchange
- NCTY Nasdaq
- XTNT Nasdaq
- Market Cap
- NCTY 75.5M
- XTNT 74.1M
- IPO Year
- NCTY 2004
- XTNT N/A
- Fundamental
- Price
- NCTY $10.95
- XTNT $0.45
- Analyst Decision
- NCTY
- XTNT Strong Buy
- Analyst Count
- NCTY 0
- XTNT 1
- Target Price
- NCTY N/A
- XTNT $3.00
- AVG Volume (30 Days)
- NCTY 127.6K
- XTNT 75.9K
- Earning Date
- NCTY 01-01-0001
- XTNT 11-12-2024
- Dividend Yield
- NCTY N/A
- XTNT N/A
- EPS Growth
- NCTY N/A
- XTNT N/A
- EPS
- NCTY 0.84
- XTNT N/A
- Revenue
- NCTY $25,250,543.00
- XTNT $113,862,000.00
- Revenue This Year
- NCTY N/A
- XTNT $31.82
- Revenue Next Year
- NCTY N/A
- XTNT $13.64
- P/E Ratio
- NCTY $35.07
- XTNT N/A
- Revenue Growth
- NCTY 65.70
- XTNT 45.11
- 52 Week Low
- NCTY $4.03
- XTNT $0.43
- 52 Week High
- NCTY $11.49
- XTNT $1.45
- Technical
- Relative Strength Index (RSI)
- NCTY 73.75
- XTNT 29.47
- Support Level
- NCTY $8.25
- XTNT $0.46
- Resistance Level
- NCTY $8.70
- XTNT $0.54
- Average True Range (ATR)
- NCTY 0.51
- XTNT 0.02
- MACD
- NCTY 0.09
- XTNT -0.00
- Stochastic Oscillator
- NCTY 100.00
- XTNT 9.09
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China and other areas.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.